A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and Chronic Hepatitis B Patients
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability, and pharmacokinetics of AHB-137
subcutaneous injection in healthy participants after single and multiple doses. In addition,
the study will evaluate the antiviral efficacy of AHB-137 in chronic hepatitis B (CHB)
patients following a multiple dosing regimen.